available for iOS, Android and web
May 01, 2014
Earnings per share for 2014 now projected at US$2.30-US$2.40.
Seeking expressions of interest from academic and research groups.
Funding call aims to reduce laboratory-animal numbers, suffering
April 29, 2014
New funding streams to encourage research partnerships
Focus on design, planning and execution of Phase II-IV trials
Joint initiative by CIHR, Rx&D and ACAHO/CHA
April 24, 2014
Adds capabilities in epidemiological, observational studies
Regional growth opportunities seen in contract research services
Catalyst Corporate Finance cites preference for 'one-stop shops'
April 22, 2014
Personalised trial for lung cancer could incorporate up to 14 different drugs
A waste of time or way forward?
PharmaTimes 2014 Copyright | RSS Feed Subscriptions